Mir­ror­ing Sen­ate coun­ter­parts, House com­mit­tee ad­vances PBM re­forms

The House En­er­gy & Com­merce Com­mit­tee ad­vanced mul­ti­ple bills to the House floor in a sev­en-hour hear­ing Wednes­day, some of which in­clud­ed mea­sures to ad­dress drug pric­ing trans­paren­cy and PBMs.

The high­lights in­clud­ed two bills, among oth­er health­care mea­sures, that would ad­vance ac­count­abil­i­ty around PBMs and on drug pric­ing, in­clud­ing the em­bat­tled 340B pro­gram. One bill, al­so known as the “Pro­mot­ing Ac­cess to Treat­ments and In­creas­ing Ex­treme­ly Need­ed Trans­paren­cy,” or PA­TIENT Act, would ban spread pric­ing where PBMs can charge that state more than they re­im­burse phar­ma­cies. That same ban was in­clud­ed in a Sen­ate bill that al­so re­cent­ly ad­vanced out of com­mit­tee.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN